These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23528560)

  • 1. Radiosynthesis and biological evaluation of alpha-[F-18]fluoromethyl phenylalanine for brain tumor imaging.
    Huang C; Yuan L; Rich KM; McConathy J
    Nucl Med Biol; 2013 May; 40(4):498-506. PubMed ID: 23528560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosynthesis and biological evaluation of N-(2-[
    Tang C; Nie D; Tang G; Gao S; Liu S; Wen F; Tang X
    Nucl Med Biol; 2017 Jul; 50():39-46. PubMed ID: 28456080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Radiolabeling, and Biological Evaluation of (R)- and (S)-2-Amino-5-[(18)F]fluoro-2-methylpentanoic Acid ((R)-, (S)-[(18)F]FAMPe) as Potential Positron Emission Tomography Tracers for Brain Tumors.
    Bouhlel A; Zhou D; Li A; Yuan L; Rich KM; McConathy J
    J Med Chem; 2015 May; 58(9):3817-29. PubMed ID: 25843369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas.
    Sai KK; Huang C; Yuan L; Zhou D; Piwnica-Worms D; Garbow JR; Engelbach JA; Mach RH; Rich KM; McConathy J
    J Nucl Med; 2013 Jul; 54(7):1120-6. PubMed ID: 23650628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and comparative biological evaluation of L- and D-isomers of 18F-labeled fluoroalkyl phenylalanine derivatives as tumor imaging agents.
    Wang L; Lieberman BP; Plössl K; Qu W; Kung HF
    Nucl Med Biol; 2011 Apr; 38(3):301-12. PubMed ID: 21492778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
    Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
    Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of α-Methyl versus α-Hydrogen Substitution on Brain Availability and Tumor Imaging Properties of Heptanoic [F-18]Fluoroalkyl Amino Acids for Positron Emission Tomography (PET).
    Bouhlel A; Alyami W; Li A; Yuan L; Rich K; McConathy J
    J Med Chem; 2016 Apr; 59(7):3515-31. PubMed ID: 26967318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosynthesis and biological evaluation of 5-(3-[18F]fluoropropyloxy)-L-tryptophan for tumor PET imaging.
    He S; Tang G; Hu K; Wang H; Wang S; Huang T; Liang X; Tang X
    Nucl Med Biol; 2013 Aug; 40(6):801-7. PubMed ID: 23791401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
    Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
    J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, uptake mechanism characterization and biological evaluation of (18)F labeled fluoroalkyl phenylalanine analogs as potential PET imaging agents.
    Wang L; Qu W; Lieberman BP; Plössl K; Kung HF
    Nucl Med Biol; 2011 Jan; 38(1):53-62. PubMed ID: 21220129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
    Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA
    Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re(CO)
    Lipowska M; Jarkas N; Voll RJ; Nye JA; Klenc J; Goodman MM; Taylor AT
    Nucl Med Biol; 2018 Mar; 58():42-50. PubMed ID: 29367095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
    Israel I; Brandau W; Farmakis G; Samnick S
    Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosynthesis and evaluation of N
    Wang H; Zhao Q; Dong W; Yang L; Lu K; Guo X; Liu H; Wei H; Cheng Y; Wu Z; Li S
    Nucl Med Biol; 2021; 94-95():98-105. PubMed ID: 33621898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and preliminary biological evaluation of S-11C-methyl-D-cysteine as a new amino acid PET tracer for cancer imaging.
    Huang T; Tang G; Wang H; Nie D; Tang X; Liang X; Hu K; Yi C; Yao B; Tang C
    Amino Acids; 2015 Apr; 47(4):719-27. PubMed ID: 25534431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of 2-amino-5-(4-[(18)F]fluorophenyl)pent-4-ynoic acid ([(18)F]FPhPA): a novel (18)F-labeled amino acid for oncologic PET imaging.
    Way JD; Wang M; Hamann I; Wuest M; Wuest F
    Nucl Med Biol; 2014 Sep; 41(8):660-9. PubMed ID: 24993371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical evaluation of an
    Yang X; Liu Z; Zhang H; Li Z; Munasinghe JP; Niu G; Teng G; Chen X
    Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):585-592. PubMed ID: 29285548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of an N-[
    Wu Z; Ma J; Brownell AL; Wang H; Li C; Meng X; Yuan L; Liu H; Li S; Xie J
    Nucl Med Biol; 2018 Nov; 66():40-48. PubMed ID: 30248568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, radiolabeling, and biological evaluation of (R)- and (S)-2-amino-3-[(18)F]fluoro-2-methylpropanoic acid (FAMP) and (R)- and (S)-3-[(18)F]fluoro-2-methyl-2-N-(methylamino)propanoic acid (NMeFAMP) as potential PET radioligands for imaging brain tumors.
    Yu W; McConathy J; Williams L; Camp VM; Malveaux EJ; Zhang Z; Olson JJ; Goodman MM
    J Med Chem; 2010 Jan; 53(2):876-86. PubMed ID: 20028004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.